Search

Your search keyword '"John D. Pauling"' showing total 70 results

Search Constraints

Start Over You searched for: Author "John D. Pauling" Remove constraint Author: "John D. Pauling" Topic humans Remove constraint Topic: humans
70 results on '"John D. Pauling"'

Search Results

1. Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: an international collaborative scoping review

2. Factors Influencing Patient Decision‐Making Concerning Treatment Escalation in Raynaud’s Phenomenon Secondary to Systemic Sclerosis

Catalog

Books, media, physical & digital resources

3. COVAD survey 2 long-term outcomes: unmet need and protocol

4. Effect of Coping Strategies on Patient and Physician Perceptions of Disease Severity and Disability in Systemic Sclerosis

5. Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure

6. Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: A systematic literature review

7. Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis

8. The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis

9. Raynaud phenomenon and digital ulcers in systemic sclerosis

10. Recommendations for the execution and reporting of skin ultrasound in systemic sclerosis: an international collaboration under the WSF skin ultrasound group

11. Diagnostic test accuracy of artificial intelligence analysis of cross-sectional imaging in pulmonary hypertension: a systematic literature review

12. Ultrasound and elastography in the assessment of skin involvement in systemic sclerosis: A systematic literature review focusing on validation and standardization - WSF Skin Ultrasound Group

13. Patient experiences of digital ulcer development and evolution in systemic sclerosis

14. Raynaud’s phenomenon—an update on diagnosis, classification and management

15. The efficacy of dietary intervention on gastrointestinal involvement in systemic sclerosis: A systematic literature review

16. Factors Influencing Raynaud Condition Score Diary Outcomes in Systemic Sclerosis

17. Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020

18. Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: A systematic review and international Delphi consensus

19. Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services:comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services

21. COVID-19 vaccination in autoimmune disease (COVAD) survey protocol

22. How do patients define Raynaud's phenomenon? Differences between primary and secondary disease

23. Evaluation of a patient self-stratification methodology to identify those in need of shielding during COVID-19

24. High frequency ultrasound assessment of systemic sclerosis skin involvement:intra-observer repeatability and relationship with clinician assessment and dermal collagen content

25. Multidisciplinary collaboration among young specialists

26. Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders

27. The aetiopathogenic significance, clinical relevance and therapeutic implications of vasculopathy in idiopathic inflammatory myopathy

28. What narrative devices do people with systemic sclerosis use to describe the experience of pain from digital ulcers:a multicentre focus group study at UK scleroderma centres

29. Differing commissioning arrangements may contribute to geographic variation in clinical management of digital ulcers in systemic sclerosis

30. Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis

31. Qualitative Methods to Advance Care, Diagnosis, and Therapy in Rheumatic Diseases

32. The challenge of establishing treatment efficacy for cutaneous vascular manifestations of systemic sclerosis

33. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis

34. Raynaud phenomenon and digital ulcers in systemic sclerosis

35. Patient organisation-led initiatives can play an important role in raising awareness about Raynaud’s phenomenon and encourage earlier healthcare utilisation for high-risk groups

36. Early response to anti-TNF predicts long-term outcomes including sustained remission:an analysis of the BSRBR-RA

37. Gender-related differences in systemic sclerosis

39. Multicenter Qualitative Study Exploring the Patient Experience of Digital Ulcers in Systemic Sclerosis

40. Orofacial manifestations of systemic sclerosis

41. Symptoms of Raynaud’s phenomenon (RP) in fibromyalgia syndrome are similar to those reported in primary RP despite differences in objective assessment of digital microvascular function and morphology

42. Fulminant immune-mediated necrotising myopathy (IMNM) mimicking myocardial infarction with non-obstructive coronary arteries (MINOCA)

43. The Role of Vascular Endothelial Growth Factor in Systemic Sclerosis

44. EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases

45. The patient experience of Raynaud's phenomenon in systemic sclerosis

46. Behaviour change interventions for the management of Raynaud's phenomenon: a systematic literature review

47. Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis

48. Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients

49. Exploring the patient experience of digital ulcers in systemic sclerosis

50. Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity